|European Case Law Identifier:||ECLI:EP:BA:1999:T027295.19990415|
|Date of decision:||15 April 1999|
|Case number:||T 0272/95|
|Decision of the Enlarged Board of Appeal:||G 0003/99|
|IPC class:||C12N 15/16|
|Language of proceedings:||EN|
|Download and more information:||
|Title of application:||Molecular cloning and characterization of a further gene sequence coding for human relaxin|
|Applicant name:||Howard Florey Institute of Experimental Physiology and Medicine|
|Opponent name:||Aglietta, Amendola et al., Fraktion der GrÃ¼nen im EP|
|Headnote:||The following questions are referred to the Enlarged Board of Appeal: 1. Is an opposition admissible which otherwise meets the requirements of Article 99 EPC and Rule 55 EPC if it is filed jointly by two or more persons and only one opposition fee is paid?
2. If the answer to question 1 is in the affirmative and a common representative was named under Rule 100(1) EPC in the notice of opposition, is an appeal valid even if it is not filed by this person?
3. If the answers to questions 1 and 2 are in the affirmative, which other requirements, if any, have to be met by a joint opposition or a joint appeal in order to safeguard the rights of the patent proprietor?
|Relevant legal provisions:|
|Keywords:||Joint oppositions - fees due - common representative - joint appeals - admissibility - important point of law - referral to the Enlarged Board of Appeal|
Date retrieved: 30 December 2018